Effect of TU-100, a traditional Japanese medicine, administered after hepatic resection in patients with liver cancer: a multi-center, phase III trial (JFMC40-1001)

International Journal of Clinical Oncology

Volumn 20, Issue 1, 2015, Pages 95-104

  Shimada, Mitsuo ^a   Morine, Yuji ^a   Nagano, Hiroaki ^b   Hatano, Etsuro ^c   Kaiho, Takashi ^d   Miyazaki, Masaru ^e   Kono, Toru ^f   Kamiyama, Toshiya ^g   Morita, Satoshi ^h   Sakamoto, Junichi ⁱ   Kusano, Mitsuo ^j   Saji, Shigetoyo ⁱ   Kanematsu, Takashi ^k   Kitajima, Masaki ^l  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b OSAKA UNIVERSITY   (Japan)

^c KYOTO UNIVERSITY   (Japan)

^d KIMITSU CHUO HOSPITAL   (Japan)

^e CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f Sapporo Higashi Tokushukai Hospital   (Japan)

^g HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^h YOKOHAMA CITY UNIVERSITY   (Japan)

ⁱ Japanese Foundation for Multidisciplinary Treatment of Cancer   (Japan)

^j KUSHIRO ROSAI HOSPITAL   (Japan)

^k Nagasaki Municipal Hospital   (Japan)

^l INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

more..

Author keywords

Bowel movement; C reactive protein; Inflammation; Japanese medicine; Liver damage

Indexed keywords

12,13-DIHYDRO-N-METHYL-6,11,13-TRIOXO-5H-BENZO(4,5)CYCLOHEPTA(1,2-B)NAPHTHALEN-5,12-IMINE; AMMONIA; C REACTIVE PROTEIN; NAPHTHOQUINONE;

AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL DISEASES; HUMAN; LIVER; LIVER NEOPLASMS; LIVER RESECTION; MALE; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; ORIENTAL MEDICINE; PHASE 3 CLINICAL TRIAL; POSTOPERATIVE PERIOD; PROCEDURES; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMMONIA; ASIAN CONTINENTAL ANCESTRY GROUP; C-REACTIVE PROTEIN; FEMALE; GASTROINTESTINAL DISEASES; HEPATECTOMY; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MEDICINE, EAST ASIAN TRADITIONAL; MIDDLE AGED; NAPHTHOQUINONES; POSTOPERATIVE PERIOD;

EID: 84894631671     PISSN: 13419625     EISSN: 14377772     Source Type: Journal    
DOI: 10.1007/s10147-014-0678-2     Document Type: Article

References (39)

1. Furukawa Y, Hanyu N, Nakada K et al (1999) Effects of the Chinese herb medicine “Dai-kenchu-to” on GI motility and for treatment of bowel obstruction. Gastroenterology 116:A811
2. Iwai N, Kume Y, Kimura O et al (2007) Effects of herbal medicine Dai-Kenchu-to on anorectal function in children with severe constipation. Eur J Pediatr Surg 17:115–118
3. Sakakibara R, Odaka T, Lui Z et al (2005) Dietary herb extract dai-kenchu-to ameliorates constipation in parkinsonian patients (Parkinson’s disease and multiple system atrophy). Mov Disord 20:261–262
4. Ohya T, Usui Y, Arii S et al (2003) Effect of dai-kenchu-to on obstructive bowel disease in children. Am J Chin Med 31:129–135
5. Nakamura T, Sakai A, Isogami I et al (2002) Abatement of morphine-induced slowing in gastrointestinal transit by Dai-kenchu-to, a traditional Japanese herbal medicine. Jpn J Pharmacol 88:217–221
6. Satoh K, Kase Y, Yuzurihara M et al (2003) Effect of Dai-kenchu-to (Da-Jian-Zhong-Tang) on the delayed intestinal propulsion induced by chlorpromazine in mice. J Ethnopharmacol 86:37–44
7. Satoh K, Hayakawa T, Kase Y et al (2001) Mechanisms for contractile effect of dai-kenchu-to in isolated guinea pig ileum. Dig Dis Sci 46:250–256
8. Hayakawa T, Kase Y, Saito K et al (1999) Effects of Dai-kenchu-to on intestinal obstruction following laparotomy. J Smooth Muscle Res 35:47–54
9. Yoshikawa K, Kurita N, Higashijima J et al (2008) Kampo medicine “Dai-kenchu-to” prevents bacterial translocation in rats. Dig Dis Sci 53:1824–1831
10. Chikakiyo M, Shimada M, Nakao T et al (2012) Kampo medicine “Dai-kenchu-to” prevents CPT-11-induced small-intestinal injury in rats. Surg Today 42:60–67
11. Sato Y, Katagiri F, Inoue S et al (2004) Dai-kenchu-to raises levels of calcitonin gene-related peptide and substance P in human plasma. Biol Pharm Bull 27:1875–1877
12. Sato Y, Inoue S, Katagiri F et al (2006) Effects of pirenzepine on Dai-kenchu-to-induced elevation of the plasma neuropeptide levels in humans. Biol Pharm Bull 29:166–171
13. Suehiro T, Matsumata T, Shikada Y et al (2005) The effect of the herbal medicines dai-kenchu-to and keishi-bukuryo-gan on bowel movement after colorectal surgery. Hepatogastroenterology 52:97–100
14. Endo S, Nishida T, Nishikawa K et al (2006) Dai-kenchu-to, a Chinese herbal medicine, improves stasis of patients with total gastrectomy and jejunal pouch interposition. Am J Surg 192:9–13
15. Kaiho T, Tanaka T, Tsuchiya S et al (2005) Effect of the herbal medicine Dai-kenchu-to on serum ammonia in hepatectomized patients. Hepatogastroenterology 52:161–165
16. Kono T, Kanematsu T, Kitajima M (2009) Exodus of Kampo, traditional Japanese medicine, from the complementary and alternative medicines: is it time yet? Surgery 146:837–840
17. Manabe N, Camilleri M, Rao A et al (2010) Effect of daikenchuto (TU-100) on gastrointestinal and colonic transit in humans. Am J Physiol Gastrointest Liver Physiol 298:G970–G975
18. Liver Cancer Study Group of Japan (1997) Classification of primary liver cancer, 1 English edn. Kanehara, Tokyo
19. Nagano T, Itoh H, Takeyama M (2000) Effects of Dai-kenchu-to on levels of 5-hydroxytryptamine (serotonin) and vasoactive intestinal peptides in human plasma. Biol Pharm Bull 23:352–353
20. Nagano T, Itoh H, Takeyama M (1999) Effect of Dai-kenchu-to on levels of 3 brain-gut peptides (motilin, gastrin and somatostatin) in human plasma. Biol Pharm Bull 22:1131–1133
21. Itoh T, Yamakawa J, Mai M et al (2002) The effect of the herbal medicine daikenchu-to on post-operative ileus. J Int Med Res 30:428–432
22. Yoshikawa K, Shimada M, Nishioka M et al (2012) The effects of the Kampo medicine (Japanese herbal medicine) “Daikenchuto” on the surgical inflammatory response following laparoscopic colorectal resection. Surg Today 42:646–651
23. Kito Y, Suzuki H (2006) Effects of Dai-kenchu-to on spontaneous activity in the mouse small intestine. J Smooth Muscle Res 42:189–201
24. Fukuda H, Chen C, Mantyh C et al (2006) The herbal medicine, Dai-Kenchu-to, accelerates delayed gastrointestinal transit after an operation on rats. J Surg Res 131:290–295
25. Tokita Y, Yuzurihara M, Sakaguchi M et al (2007) The pharmacological effects of Daikenchuto, a traditional herbal medicine, on delayed gastrointestinal transit in rat postoperative ileus. J Pharmacol Sci 104:303–310
26. Satoh K, Kase Y, Hayakawa T et al (2001) Dai-kenchu-to enhances accelerated small intestinal movement. Biol Pharm Bull 24:1122–1126
27. Kawasaki N, Nakada K, Nakayoshi T et al (2007) Effect of Dai-kenchu-to on gastrointestinal motility based on differences in the site and timing of administration. Dig Dis Sci 52:2684–2694
28. Shibata C, Sasaki I, Naito H et al (1999) The herbal medicine Dai-Kenchu-Tou stimulates upper gut motility through cholinergic and 5-hydroxytryptamine 3 receptors in conscious dogs. Surgery 126:918–924
29. Kinoshita Y, Inui T, Chiba T (1993) Calcitonin gene-related peptide: a neurotransmitter involved in capsaicin-sensitive afferent nerve-mediated gastric mucosal protection. J Clin Gastroenterol 17:S27–S32
30. Reinshagen M, Patel A, Sottili M et al (1994) Protective function of extrinsic sensory neurons in acute rabbit experimental colitis. Gastroenterology 106:1208–1214
31. Kono T, Koseki T, Chiba S et al (2008) Colonic vascular conductance increased by Daikenchuto via calcitonin gene-related peptide and receptor-activity modifying protein 1. J Surg Res 150:78–84
32. Genesca J, Gonzalez A, Catalan R et al (1999) Adrenomedullin, a vasodilator peptide implicated in hemodynamic alterations of liver cirrhosis: relationship to nitric oxide. Dig Dis Sci 44:372–376
33. Kono T, Kaneko A, Hira Y et al (2010) Anti-colitis and -adhesion effects of daikenchuto via endogenous adrenomedullin enhancement in Crohn’s disease mouse model. J Crohns Colitis 4:161–170
34. Kono T, Omiya Y, Hira Y et al (2011) Daikenchuto (TU-100) ameliorates colon microvascular dysfunction via endogenous adrenomedullin in Crohn’s disease rat model. J Gastroenterol 46:1187–1196
35. Ogasawara T, Morine Y, Ikemoto T et al (2008) Influence of Dai-kenchu-to (DKT) on human portal blood flow. Hepatogastroenterology 55:574–577
36. Narita M, Hatano E, Tamaki N et al (2009) Dai-kenchu-to attenuates rat sinusoidal obstruction syndrome by inhibiting the accumulation of neutrophils in the liver. J Gastroenterol Hepatol 24:1051–1057
37. Seo YS, Shah VH (2012) The role of gut-liver axis in the pathogenesis of liver cirrhosis and portal hypertension. Clin Mol Hepatol 18:337–346
38. Bellot P, Francés R, Such J (2013) Pathological bacterial translocation in cirrhosis: pathophysiology, diagnosis and clinical implications. Liver Int 33:31–39
39. Basu S (2003) Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrients. Toxicology 189:113–127